PEB - Pacific Edge Ltd

[jridler]

Revenues will depend on the uptake of Cxbladder by other health providers and the speed at which it happens.We may see a flood of announcements as,in my opinion,this will happen quite rapidly.

Long-time holder, seldom poster. Although the recent action is certainly exciting, and without wanting to temper this excitement too much (goodness knows, it is well overdue), I do want to add some balance to the view of rapid scaling. The Kaiser Permanente user program for Cxbladder was commenced mid-2015. We have now, five years later in mid-2020, achieved commercial approval. You can see in reports dating back to the completion of the user program in 2017 that discussions were "progressing", "continuing" or similar such verb. In my view, a tipping point has recently been reached with the Kaiser Permanente commercial approval and LCD inclusion - however, I would be very deliberate in your definition and personal expectations of "quite rapidly", given the glacial pace at which, historically, commercial milestones have progressed. This is no slight against the company, but is more reflective of the nature of the industry.

[Minerbarejet]

Kaiser Permanente is a Healthcare Provider.
Medicare is a Public Healthcare Insurer

Therefore a person going to a KP clinic having Medicare as their insurance will now be told that cxBladder is now covered by their insurance.
Therefore you cannot add Medicare totals to KP totals for an estimate of income.

The Medicare totals owing come from all the Healthcare Providers in the US including KP with patients having Medicare Insurance.
Think that is the way it works.

This needs some clarification at this point.
Further research of published PEB news letters reveals that Kaiser Permanente intends utilizing cxBladder for the evaluation of haematuria.

This is the Triage test not Monitor or Detect.

Monitor and Detect have CMS reimbursement codes but Triage does not as yet.
I would hope that the Triage code would be forthcoming in short order to cover those with Medicare coverage being evaluated by KP
KP being an insurer as well as provider have their own plans and can therefore do what they like with cx bladder utilisation in that capacity.

[nevchev]

Long-time holder, seldom poster. Although the recent action is certainly exciting, and without wanting to temper this excitement too much (goodness knows, it is well overdue), I do want to add some balance to the view of rapid scaling. The Kaiser Permanente user program for Cxbladder was commenced mid-2015. We have now, five years later in mid-2020, achieved commercial approval. You can see in reports dating back to the completion of the user program in 2017 that discussions were "progressing", "continuing" or similar such verb. In my view, a tipping point has recently been reached with the Kaiser Permanente commercial approval and LCD inclusion - however, I would be very deliberate in your definition and personal expectations of "quite rapidly", given the glacial pace at which, historically, commercial milestones have progressed. This is no slight against the company, but is more reflective of the nature of the industry.

My point was that coverage by medicare now enables many more health care pro viders to be able to offer Cxbladder as an alternative to other options currently available.In the current climate,i can see home based testing as been a preferred method.It will be interesting to see how this unfolds

[tango]

I thought that PEB were still awaiting FDA approval and that money can't be collected until the approval comes through? Can someone clarify that for me??? It seems an exciting opportunity but a huge risk until the approval comes through

[baaantom]

I thought that PEB were still awaiting FDA approval and that money can't be collected until the approval comes through? Can someone clarify that for me??? It seems an exciting opportunity but a huge risk until the approval comes through

Based on my understanding, FDA approval is necessary when the product is being sold direct to the patient. PEB sells direct to the healthcare insurer/provider rather than to the patient.

PEB has said they specifically did not want to go down the FDA approval route.

[tango]

Based on my understanding, FDA approval is necessary when the product is being sold direct to the patient. PEB sells direct to the healthcare insurer/provider rather than to the patient.

PEB has said they specifically did not want to go down the FDA approval route.

Thanks for that!

I must be out of date. I saw press releases where PEB were looking at FDA approval. Maybe the strategy has changed. I was following PEB for a while and then got distracted. Watching them again now 😂

[youngatheart]

I predict sp will be $1.00 by Friday... If not sooner!

[nevchev]

I predict sp will be $1.00 by Friday... If not sooner!

Big call but looking like a strong open so you may be right

[tango]

Big call but looking like a strong open so you may be right

Sometimes it opens strong and dips away...

[Leftfield]

I predict sp will be $1.00 by Friday... If not sooner!

Hope you are right! .......in the meantime here's what the ODT had to say about PEB's 'Huge Achievement.'